Developer docs
API playgroundTry for free, no card

Search company profiles

Sooam Biotech

Full company profile

uuid0023wd5

Namestring
Sooam Biotech
Legal namestring
Sooam Biotech Research Foundation
Websiteurl
en.sooam.com
Company typeenum
Private
Founded yearint
2006
Descriptiontext

Sooam Biotech Research Foundation is a Seoul-based, non-profit research foundation founded in 2006 that operates the world's only commercial dog cloning service. The foundation's core technology is Somatic Cell Nuclear Transfer (SCNT), with extensions into Interspecies SCNT (iSCNT), embryonic stem cell derivation, and transgenic animal production. Sooam generated the first cloned dogs and the first interspecies Canidae clones (coyotes from domestic dog oocytes) and produced transgenic beagles for Alzheimer's research. Commercial revenue is generated primarily through one-off dog cloning services sold to private pet owners at approximately $60,000 per clone, with ancillary income from government and university research agreements (National 119 Rescue Service, Gyeonggi Province, Sungduk University, Rural Development Administration of Korea). The foundation maintains international research collaborations — most prominently a three-party Russia-China-Korea mammoth restoration program with North-Eastern Federal University and BGI — and operates an internship pipeline for international students. It is led by Dr. Hwang Woo-suk, founder and CTO, who pioneered SCNT-derived human embryonic stem cell lines (Sooam-hES-1, registered with the Korea National Stem Cell Bank in 2016).

The foundation's go-to-market is sales-led and direct: private clients and institutional partners engage Sooam directly to provide somatic cell samples, which are processed into clones at the Seoul Guro-gu headquarters (a facility roughly ten times larger than the original Yongin site following the late-2011 relocation). Distribution is global for pet-owner services and concentrated in Korea, Russia, and China for research collaborations. The foundation monetizes through pay-as-you-go cloning fees, government research contracts, and international consortium participation, and protects its position through patents granted in Korea, the EU, Canada, and New Zealand covering dog cloning efficiency and embryonic stem cell methodologies. Pricing is not publicly disclosed on the company website; the $60,000 per dog figure is sourced from a 2014 Channel 4 UK documentary. Marketing and demand generation have historically run through earned media — TLC/Discovery's "I Cloned My Pet" (2012), National Geographic's "Mammoth: Back from the Dead" (2013), and Vanity Fair (2018) — rather than paid acquisition.

The business model is unusual for a biotechnology organization: as a non-profit foundation with 1-10 employees, Sooam combines commercial pet-cloning revenue with grant-funded research and international collaboration, channeling proceeds into ambitious long-horizon programs (mammoth restoration, human stem cell characterization) that have no near-term commercialization pathway. This structure limits scalability but preserves scientific independence, and concentrates execution risk on a small leadership team.

Short descriptiontext

Sooam Biotech Research Foundation is a Seoul-based non-profit research organization that operates the world's only commercial dog cloning service using Somatic Cell Nuclear Transfer (SCNT), serving private pet owners at roughly $60,000 per clone alongside government and university research contracts.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersSeoul, South Korea
HQ citystring
Seoul
HQ countrystring
South Korea
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
animal cloning services, somatic cell nuclear transfer, dog cloning, embryonic stem cell lines, wildlife de-extinction research
Industry3 codes
PRIMARYAFAEAJAL
Cloning & Advanced Reproductive Technologies Services
SECONDARYHLAMANAJ
Cryopreservation, Biobanking & Cell Banking (Cord/Adipose/MSC)
Healthcare & Life Sciences/Veterinary & Animal Health/Regenerative Medicine for Animals
SECONDARYBPAKAKAL
K9 Breeding, Procurement & Deployment Services
NAICS code3 codes
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Biological Product (except Diagnostic) Manufacturing325414
  • Scientific Research and Development Services5417
SIC code3 codes
  • Services-Commercial Physical & Biological Research8731
  • Biological Products, (No Disgnostic Substances)2836
  • Agricultural Prod-Livestock & Animal Specialties200
Product category
Animal Cloning Services
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Dog Cloning Services
TypeOne Time License
Description

Commercial dog cloning service for private pet owners. Clients provide somatic cells from their pets which are used to create clones.

en.sooam.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Operations, Infrastructure
Pricing details1 tier
1Dog cloning at $60,000
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Dog cloning service priced at approximately $60,000 USD as referenced in Channel 4 UK documentary 'The £60,000 Puppy: Cloning Man's Best Friend'

en.sooam.com
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Core offering1 text field

Sooam Biotech Research Foundation provides commercial dog cloning services using proprietary Somatic Cell Nuclear Transfer (SCNT) technology, priced at approximately $60,000 USD per dog, where clients provide somatic cells from their pets to create genetic copies. The foundation also conducts embryonic stem cell line research (SCNT-1), interspecies cloning (coyotes via domestic dog eggs), transgenic animal production, and woolly mammoth restoration research in collaboration with international partners.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • First successful dog cloning in the world
+2 more records
Product overview1 text field

Sooam Biotech Research Foundation (Sooam BRF) is a biotechnology research organization specializing in somatic cell nuclear transfer (SCNT) cloning technology. The company offers dog cloning services as its primary commercial offering, along with embryonic stem cell line development, endangered species cloning research, and interspecies cloning technology development. The organization operates as a research foundation with technology transfer and training components, providing its cloning expertise through collaborations with international research institutions. Sooam BRF's core technology involves SCNT-based animal cloning, with applications across dog cloning, endangered species preservation, and the ambitious mammoth restoration project conducted with international partners.

Product and service4 records
1Commercial Dog Cloning Service
CategoryAnimal Cloning Services
Description

Commercial dog cloning service for private pet owners globally, where clients provide somatic cells from their pet to generate a genetic copy using Sooam's proprietary canine Somatic Cell Nuclear Transfer (SCNT) technology.

2Interspecies SCNT Cloning Service (Canidae)
CategoryAnimal Cloning Services
Description

Interspecies Somatic Cell Nuclear Transfer (iSCNT) cloning using domestic dog eggs to clone coyotes (and related Canidae), delivered to government and conservation partners for endangered species preservation and wild animal rescue programs.

3SCNT-1 / Sooam-hES-1 Embryonic Stem Cell Line
CategoryStem Cell Lines and Regenerative Medicine
Description

Patient-specific human embryonic stem cell line derived from somatic cell nuclear transfer (SCNT), developed and established by Dr. Hwang Woo-suk; registered with the Korean National Stem Cell Bank and protected by patents in Korea, EU, Canada, and New Zealand.

4Transgenic Animal Production
CategoryTransgenic Animal Models / Biomedical Research
Description

Production of transgenic animals for biomedical research and biopharma applications, including transgenic beagles for Alzheimer's disease research delivered to research partners and a transgenic cow for interferon production delivered under a national R&D project with the Rural Development Administration of Korea.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
1National 119 Rescue Service
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2012-12-26
Description

MOU signed for preserving excellent pedigree rescue dogs by SCNT cloning technology. Sooam contributed two cloned rescue dogs named Raccoons to be trained as working rescue dogs.

en.sooam.com
2North-Eastern Federal University (NEFU), Russia
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2012-03-13
Description

Korea-Russia research collaboration agreement for mammoth restoration. NEFU provides biological samples from mammoth remains found in Sakha Republic, Russia. Sooam provides cloning technology expertise. Joint establishment of mobile laboratory at NEFU campus for mammoth sample research. Russian scientists trained at Sooam's Korea facility.

en.sooam.com
3Sungduk University
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2011-07-01
Description

Five Jurorong clones delivered to Sungduk University for use as research dogs. Adoption ceremony held at Sooam.

en.sooam.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2011-06-10
Description

Research agreement for collaborative research on endangered species cloning. Sooam authorized to obtain somatic cells from endangered species and deliver cloned endangered animals.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2011-05-01
Description

National R&D project agreement for delivery of transgenic cow for production of interferon.

6China National Genebank (BGI)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Three-party research collaboration between Korea, China and Russia for mammoth restoration. BGI, Sooam, and North-Eastern Federal University collaborate to retrieve and research mammoth samples for understanding their genomics and potentially cloning a live mammoth from a surrogate elephant.

en.sooam.com
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

US livestock reproductive technology company offering cloning, IVF, and embryo transfer for cattle and other species. Comparable SCNT platform applied to a different (livestock) end market — broader agricultural incumbent.

2My Friend Again
TypeDirect peer
Description

Spain-based pet cloning service that has partnered with Sooam-era technology. Comparable business model offering dog and cat cloning to European consumers at premium prices, competing for the same international pet-owner demand.

3Clonaid
TypeEmerging player
Description

Controversial human and animal cloning company. While human-focused in claims, it operates in the same cloning-services category and competes for media attention and fringe-market pet-owner demand.

TypeBroad incumbent
Description

US regenerative medicine company using SCNT-derived genetically modified pigs for xenotransplantation. Comparable in using SCNT as a production platform for biological products, though targeting therapeutics rather than companion animals.

TypeDirect peer
Description

Beijing-based pet cloning company offering commercial dog and cat cloning services, Sooam's most direct global competitor. Uses similar SCNT methodology and serves overlapping private-pet-owner customer segments across Asia.

TypeEmerging player
Description

US biotech applying gene editing and reproductive technology to xenotransplantation. Uses overlapping embryology/SCNT-adjacent capabilities for organ transplant rather than pet cloning, but is a scientific peer in advanced reproductive biotechnology.

7PerPETuate
TypeEmerging player
Description

US-based pet genetic preservation company that stores somatic cells from pets for future cloning. Adjacent to Sooam's service — overlaps on the front-end (cell preservation) but focuses on storage rather than active cloning.

TypeOthers
Description

Active collaboration partner on Sooam's mammoth restoration project. Genomics sequencing peer and ecosystem participant rather than a direct competitor; comparable in scale and scientific ambition within Asian biotech.

9Roslin Institute
TypeBroad incumbent
Description

University of Edinburgh research institute that created Dolly the sheep and pioneered mammalian SCNT. A scientific peer and historical reference point; broader biotech/transgenic animal research portfolio rather than commercial cloning services.

TypeDirect peer
Description

US-based pet genetic preservation and cloning service (horses, dogs, cats). Directly comparable commercial model to Sooam's dog cloning service, serving North American private pet owners and elite breeding programs.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance6 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Sooam Biotech

Animal Cloning Servicesen.sooam.com

Sooam Biotech Research Foundation is a Seoul-based non-profit research organization that operates the world's only commercial dog cloning service using Somatic Cell Nuclear Transfer (SCNT), serving private pet owners at roughly $60,000 per clone alongside government and university research contracts.

What Sooam Biotech does

Sooam Biotech Research Foundation is a Seoul-based, non-profit research foundation founded in 2006 that operates the world's only commercial dog cloning service. The foundation's core technology is Somatic Cell Nuclear Transfer (SCNT), with extensions into Interspecies SCNT (iSCNT), embryonic stem cell derivation, and transgenic animal production. Sooam generated the first cloned dogs and the first interspecies Canidae clones (coyotes from domestic dog oocytes) and produced transgenic beagles for Alzheimer's research. Commercial revenue is generated primarily through one-off dog cloning services sold to private pet owners at approximately $60,000 per clone, with ancillary income from government and university research agreements (National 119 Rescue Service, Gyeonggi Province, Sungduk University, Rural Development Administration of Korea). The foundation maintains international research collaborations — most prominently a three-party Russia-China-Korea mammoth restoration program with North-Eastern Federal University and BGI — and operates an internship pipeline for international students. It is led by Dr. Hwang Woo-suk, founder and CTO, who pioneered SCNT-derived human embryonic stem cell lines (Sooam-hES-1, registered with the Korea National Stem Cell Bank in 2016).

The foundation's go-to-market is sales-led and direct: private clients and institutional partners engage Sooam directly to provide somatic cell samples, which are processed into clones at the Seoul Guro-gu headquarters (a facility roughly ten times larger than the original Yongin site following the late-2011 relocation). Distribution is global for pet-owner services and concentrated in Korea, Russia, and China for research collaborations. The foundation monetizes through pay-as-you-go cloning fees, government research contracts, and international consortium participation, and protects its position through patents granted in Korea, the EU, Canada, and New Zealand covering dog cloning efficiency and embryonic stem cell methodologies. Pricing is not publicly disclosed on the company website; the $60,000 per dog figure is sourced from a 2014 Channel 4 UK documentary. Marketing and demand generation have historically run through earned media — TLC/Discovery's "I Cloned My Pet" (2012), National Geographic's "Mammoth: Back from the Dead" (2013), and Vanity Fair (2018) — rather than paid acquisition.

The business model is unusual for a biotechnology organization: as a non-profit foundation with 1-10 employees, Sooam combines commercial pet-cloning revenue with grant-funded research and international collaboration, channeling proceeds into ambitious long-horizon programs (mammoth restoration, human stem cell characterization) that have no near-term commercialization pathway. This structure limits scalability but preserves scientific independence, and concentrates execution risk on a small leadership team.

Sooam Biotech firmographics

Firmographics
Name
Sooam Biotech
Legal name
Sooam Biotech Research Foundation
Website
https://en.sooam.com
Company type
Private
Founded year
2006
Operating status
Operating
Headcount range
51–100 employees
Short description
Sooam Biotech Research Foundation is a Seoul-based non-profit research organization that operates the world's only commercial dog cloning service using Somatic Cell Nuclear Transfer (SCNT), serving private pet owners at roughly $60,000 per clone alongside government and university research contracts.
Ownership category
akta.pro rank

Sooam Biotech industry classification

Industry
Product category
Animal Cloning Services
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714), Biological Product (except Diagnostic) Manufacturing (325414), Scientific Research and Development Services (5417)
SIC
Services-Commercial Physical & Biological Research (8731), Biological Products, (No Disgnostic Substances) (2836), Agricultural Prod-Livestock & Animal Specialties (200)
akta.pro industry
PRIMARYAFAEAJAL
Cloning & Advanced Reproductive Technologies Services
SECONDARYHLAMANAJ
Cryopreservation, Biobanking & Cell Banking (Cord/Adipose/MSC)
Healthcare & Life Sciences/Veterinary & Animal Health/Regenerative Medicine for Animals
SECONDARYBPAKAKAL
K9 Breeding, Procurement & Deployment Services

Keywords

  • Animal cloning services
  • Somatic cell nuclear transfer
  • Dog cloning
  • Embryonic stem cell lines
  • Wildlife de-extinction research

Where Sooam Biotech is headquartered

Location

Headquarters

HQ city
Seoul
HQ country
South Korea
HQ region
Asia

Offices1 record

Markets served

Sooam Biotech business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Infrastructure

Revenue model

  1. Dog Cloning Services: Commercial dog cloning service for private pet owners. Clients provide somatic cells from their pets which are used to create clones.

Pricing tiers

ModelBillingPrice
One time/ perpetual licensePay-as-you-goDog cloning at $60,000

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Sooam Biotech product offering

Product offering

Core offering

Sooam Biotech Research Foundation provides commercial dog cloning services using proprietary Somatic Cell Nuclear Transfer (SCNT) technology, priced at approximately $60,000 USD per dog, where clients provide somatic cells from their pets to create genetic copies. The foundation also conducts embryonic stem cell line research (SCNT-1), interspecies cloning (coyotes via domestic dog eggs), transgenic animal production, and woolly mammoth restoration research in collaboration with international partners.

Product overview

Sooam Biotech Research Foundation (Sooam BRF) is a biotechnology research organization specializing in somatic cell nuclear transfer (SCNT) cloning technology. The company offers dog cloning services as its primary commercial offering, along with embryonic stem cell line development, endangered species cloning research, and interspecies cloning technology development. The organization operates as a research foundation with technology transfer and training components, providing its cloning expertise through collaborations with international research institutions. Sooam BRF's core technology involves SCNT-based animal cloning, with applications across dog cloning, endangered species preservation, and the ambitious mammoth restoration project conducted with international partners.

Differentiator

Problem solved

Functional benefit

Products and services

  • Commercial Dog Cloning Service Commercial dog cloning service for private pet owners globally, where clients provide somatic cells from their pet to generate a genetic copy using Sooam's proprietary canine Somatic Cell Nuclear Transfer (SCNT) technology.
  • Interspecies SCNT Cloning Service (Canidae) Interspecies Somatic Cell Nuclear Transfer (iSCNT) cloning using domestic dog eggs to clone coyotes (and related Canidae), delivered to government and conservation partners for endangered species preservation and wild animal rescue programs.
  • SCNT-1 / Sooam-hES-1 Embryonic Stem Cell Line Patient-specific human embryonic stem cell line derived from somatic cell nuclear transfer (SCNT), developed and established by Dr. Hwang Woo-suk; registered with the Korean National Stem Cell Bank and protected by patents in Korea, EU, Canada, and New Zealand.
  • Transgenic Animal Production Production of transgenic animals for biomedical research and biopharma applications, including transgenic beagles for Alzheimer's disease research delivered to research partners and a transgenic cow for interferon production delivered under a national R&D project with the Rural Development Administration of Korea.

Quantifiable outcome

  • First successful dog cloning in the world
  • +2 more outcomes

Companies that use Sooam Biotech

Customer profile

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Sooam Biotech technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Sooam Biotech partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core and minor.

  • National 119 Rescue ServicecoreStrategic or Co-development Partner · 26 December 2012MOU signed for preserving excellent pedigree rescue dogs by SCNT cloning technology. Sooam contributed two cloned rescue dogs named Raccoons to be trained as working rescue dogs.
  • North-Eastern Federal University (NEFU), RussiacoreStrategic or Co-development Partner · 13 March 2012Korea-Russia research collaboration agreement for mammoth restoration. NEFU provides biological samples from mammoth remains found in Sakha Republic, Russia. Sooam provides cloning technology expertise. Joint establishment of mobile laboratory at NEFU campus for mammoth sample research. Russian scientists trained at Sooam's Korea facility.
  • Sungduk UniversityminorStrategic or Co-development Partner · 1 July 2011Five Jurorong clones delivered to Sungduk University for use as research dogs. Adoption ceremony held at Sooam.
  • Gyeonggi ProvincecoreStrategic or Co-development Partner · 10 June 2011Research agreement for collaborative research on endangered species cloning. Sooam authorized to obtain somatic cells from endangered species and deliver cloned endangered animals.
  • Rural Development Administration of KoreaminorStrategic or Co-development Partner · 1 May 2011National R&D project agreement for delivery of transgenic cow for production of interferon.
  • China National Genebank (BGI)coreStrategic or Co-development PartnerThree-party research collaboration between Korea, China and Russia for mammoth restoration. BGI, Sooam, and North-Eastern Federal University collaborate to retrieve and research mammoth samples for understanding their genomics and potentially cloning a live mammoth from a surrogate elephant.

Scale indicators4 records

Recent moves7 records

Expansion highlights4 records

Sooam Biotech competitors and assessment

Company assessment

Broad incumbents

  • Trans Ova Genetics: US livestock reproductive technology company offering cloning, IVF, and embryo transfer for cattle and other species. Comparable SCNT platform applied to a different (livestock) end market — broader agricultural incumbent.
  • Revivicor: US regenerative medicine company using SCNT-derived genetically modified pigs for xenotransplantation. Comparable in using SCNT as a production platform for biological products, though targeting therapeutics rather than companion animals.
  • Roslin Institute: University of Edinburgh research institute that created Dolly the sheep and pioneered mammalian SCNT. A scientific peer and historical reference point; broader biotech/transgenic animal research portfolio rather than commercial cloning services.

Direct peers

  • My Friend Again: Spain-based pet cloning service that has partnered with Sooam-era technology. Comparable business model offering dog and cat cloning to European consumers at premium prices, competing for the same international pet-owner demand.
  • Sinogene: Beijing-based pet cloning company offering commercial dog and cat cloning services, Sooam's most direct global competitor. Uses similar SCNT methodology and serves overlapping private-pet-owner customer segments across Asia.
  • ViaGen Pets: US-based pet genetic preservation and cloning service (horses, dogs, cats). Directly comparable commercial model to Sooam's dog cloning service, serving North American private pet owners and elite breeding programs.

Emerging players

  • Clonaid: Controversial human and animal cloning company. While human-focused in claims, it operates in the same cloning-services category and competes for media attention and fringe-market pet-owner demand.
  • eGenesis: US biotech applying gene editing and reproductive technology to xenotransplantation. Uses overlapping embryology/SCNT-adjacent capabilities for organ transplant rather than pet cloning, but is a scientific peer in advanced reproductive biotechnology.
  • PerPETuate: US-based pet genetic preservation company that stores somatic cells from pets for future cloning. Adjacent to Sooam's service — overlaps on the front-end (cell preservation) but focuses on storage rather than active cloning.

Others

  • BGI (Beijing Genomics Institute): Active collaboration partner on Sooam's mammoth restoration project. Genomics sequencing peer and ecosystem participant rather than a direct competitor; comparable in scale and scientific ambition within Asian biotech.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Sooam Biotech social profiles

Digital presence

Sooam Biotech compliance and trust

Trust signal

Compliance6 records

Sooam Biotech financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Sooam Biotech leadership team

Management profile

Number of profiles

Profiles4 records

Sooam Biotech funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Sooam Biotech M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sooam Biotech

What does Sooam Biotech do?

Sooam Biotech Research Foundation provides commercial dog cloning services using proprietary Somatic Cell Nuclear Transfer (SCNT) technology, priced at approximately $60,000 USD per dog, where clients provide somatic cells from their pets to create genetic copies. The foundation also conducts embryonic stem cell line research (SCNT-1), interspecies cloning (coyotes via domestic dog eggs), transgenic animal production, and woolly mammoth restoration research in collaboration with international partners.

Is Sooam Biotech a public or private company?

Sooam Biotech is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Sooam Biotech founded?

Sooam Biotech was founded in 2006. It employs 51 to 100 people.

Where is Sooam Biotech based?

Sooam Biotech is headquartered in Seoul, South Korea, in the Asia region.

How does Sooam Biotech make money?

One revenue line is on record: dog Cloning Services.

Who are Sooam Biotech's main competitors?

Broad incumbents on record are Trans Ova Genetics, Revivicor and Roslin Institute. Direct peers are My Friend Again, Sinogene and ViaGen Pets. Emerging players are Clonaid, eGenesis and PerPETuate. BGI (Beijing Genomics Institute) is listed as an others.

Does Sooam Biotech have an API?

No public API is recorded for Sooam Biotech.

What industry is Sooam Biotech in?

Sooam Biotech's product category is Animal Cloning Services. Its primary akta.pro industry code is AFAEAJAL, Cloning & Advanced Reproductive Technologies Services, with a secondary code of HLAMANAJ, Cryopreservation, Biobanking & Cell Banking (Cord/Adipose/MSC). Its NAICS code is 541714 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
ForbesIf You Love Animals, Don't Clone Your PetPet cloning services like ViaGen and Sooam Biotech charge $25,000 to $50,000 for somatic cell nuclear transfer, but clones may not resemble the original due to environmental factors. The process uses surrogate animals, and no regulations exist, raising ethical concerns about animal suffering and the commodification of pets.Business InsiderHow to clone a dog in Korean lab SooamA visit to Sooam, a South Korean laboratory, revealed its dog cloning service, which has cloned over 600 dogs. The lab claims to clone dogs of any age, size, or breed, and a video outlines the steps to get a dog cloned.Business InsiderThis Korean lab has nearly perfected dog cloning, and that’s just the startSooam Biotech in South Korea has cloned a dog for a Tokyo man, with the clone arriving in November. The lab charges $100,000 per clone and has cloned over 600 dogs, with about 40-50 in care. The company also clones working dogs for police and military use.TechCrunchJust another working clone dogTwo South Korean biotech labs, Sooam Biotech Research Foundation and RNL Bio Co, are operating as the world's only commercial dog cloning services, staffed by researchers who previously worked with Hwang Woo-suk. Korea's Customs Service has become a notable client, cloning a champion sniffer dog from a champion drug-sniffing dog named Chase at a cost of $60,260 per clone — roughly half the cost of breeding and training a dog conventionally. Both labs report that working-dog and endangered-species cloning make up the bulk of their work, though RNL is preparing its first pet clone, a pit bull for a California woman, and BioArts is auctioning five pet cloning slots starting at $100,000 in partnership with Sooam.